HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $23 | +360.0% | 33,791 | +399.7% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 6,762 | +9.7% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 6,162 | -57.3% | 0.00% | – |
| Q3 2022 | $14,000 | -50.0% | 14,426 | 0.0% | 0.00% | – |
| Q2 2022 | $28,000 | -68.2% | 14,426 | -17.4% | 0.00% | – |
| Q1 2022 | $88,000 | -84.3% | 17,465 | -76.5% | 0.00% | – |
| Q4 2021 | $562,000 | +128.5% | 74,262 | +138.3% | 0.00% | – |
| Q3 2021 | $246,000 | -50.8% | 31,167 | -13.7% | 0.00% | – |
| Q2 2021 | $500,000 | +39.7% | 36,105 | +111.3% | 0.00% | – |
| Q1 2021 | $358,000 | +29.2% | 17,088 | +2.2% | 0.00% | – |
| Q4 2020 | $277,000 | +9.9% | 16,716 | +12.8% | 0.00% | – |
| Q3 2020 | $252,000 | -34.2% | 14,823 | -35.8% | 0.00% | – |
| Q2 2020 | $383,000 | +133.5% | 23,101 | +62.6% | 0.00% | – |
| Q1 2020 | $164,000 | -8.9% | 14,209 | +16.3% | 0.00% | – |
| Q4 2019 | $180,000 | +102.2% | 12,220 | +87.2% | 0.00% | – |
| Q3 2019 | $89,000 | +78.0% | 6,529 | +70.7% | 0.00% | – |
| Q2 2019 | $50,000 | +614.3% | 3,824 | +403.2% | 0.00% | – |
| Q1 2019 | $7,000 | – | 760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |